Home

TC BioPharm (Holdings) plc - Warrants (TCBPW)

0.0120
+0.0010 (9.09%)
SummaryNewsPress ReleasesChartHistorical
Previous Close0.0110
Open0.0130
Day's Range0.0120 - 0.0130
52 Week Range0.0040 - 0.0448
Volume1,600
Market Cap-
Dividend & YieldN/A (N/A)
1 Month Average Volume35,209

News & Press Releases

Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
EQNX::TICKER_START (NASDAQTCBP),NASDAQ:CRDFNASDAQCRDF)(NASDAQ:CYADNASDAQCYAD,(NASDAQ:RIGLNASDAQ),(NASDAQ:AZNAZN) EQNX::TICKER_END
Via FinancialNewsMedia · January 19, 2023
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
EQNX::TICKER_START (NASDAQTCBP) EQNX::TICKER_END
Via FinancialNewsMedia · January 19, 2023
TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemiabenzinga.com
TC Biopharm (NASDAQTCBP) NASDAQ: TCBPWNASDAQTCBPW)
Via Benzinga · November 22, 2022